(alpha)-Synuclein Cooperates with CSP(alpha) in Preventing Neurodegeneration

(alpha)-synuclein and cysteine-string protein-(alpha) (CSP(alpha)) are abundant synaptic vesicle proteins independently linked to neurodegeneration. Dominantly inherited mutations in (alpha)-synuclein cause Parkinson’s disease, but the physiological role of (alpha) -synuclein remains unknown. Deletion of CSP(alpha) produces rapidly progressive neurodegeneration in mice, presumably because the cochaperone function of CSP(alpha) is essential for neuronal survival. Here, we report the surprising finding that transgenic expression of (alpha)-synuclein abolishes the lethality and neurodegeneration caused by deletion of CSP(alpha). Conversely, ablation of endogenous synucleins exacerbates these phenotypes. Deletion of CSP(alpha) inhibits SNARE complex assembly; transgenic (alpha)synuclein ameliorates this inhibition. In preventing neurodegeneration in CSP(alpha)-deficient mice, (alpha)-synuclein does not simply substitute for CSP(alpha) but acts by a downstream mechanism that requires phospholipid binding by (alpha)-synuclein. These observations reveal a powerful in vivo activity of (alpha)-synuclein in protecting nerve terminals against injury and suggest that this activity operates in conjunction with CSP(alpha) and SNARE proteins on the presynaptic membrane interface.